BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 31985200)

  • 21. Recognition of Histone H3 Methylation States by the PHD1 Domain of Histone Demethylase KDM5A.
    Longbotham JE; Kelly MJS; Fujimori DG
    ACS Chem Biol; 2023 Sep; 18(9):1915-1925. PubMed ID: 33621062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the Ligand Preferences of the PHD1 Domain of Histone Demethylase KDM5A Reveals Tolerance for Modifications of the Q5 Residue of Histone 3.
    Anderson SE; Longbotham JE; O'Kane PT; Ugur FS; Fujimori DG; Mrksich M
    ACS Chem Biol; 2021 Jan; 16(1):205-213. PubMed ID: 33314922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Domain architecture and protein-protein interactions regulate KDM5A recruitment to the chromatin.
    Kataria A; Tyagi S
    Epigenetics; 2023 Dec; 18(1):2268813. PubMed ID: 37838974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended Recognition of the Histone H3 Tail by Histone Demethylase KDM5A.
    Petronikolou N; Longbotham JE; Fujimori DG
    Biochemistry; 2020 Feb; 59(5):647-651. PubMed ID: 31985200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone demethylase KDM5A is regulated by its reader domain through a positive-feedback mechanism.
    Torres IO; Kuchenbecker KM; Nnadi CI; Fletterick RJ; Kelly MJ; Fujimori DG
    Nat Commun; 2015 Feb; 6():6204. PubMed ID: 25686748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PI3K/AKT Signaling Regulates H3K4 Methylation in Breast Cancer.
    Spangle JM; Dreijerink KM; Groner AC; Cheng H; Ohlson CE; Reyes J; Lin CY; Bradner J; Zhao JJ; Roberts TM; Brown M
    Cell Rep; 2016 Jun; 15(12):2692-704. PubMed ID: 27292631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone demethylase KDM5A inhibits glioma cells migration and invasion by down regulating ZEB1.
    Dai B; Huang H; Guan F; Zhu G; Xiao Z; Mao B; Su H; Hu Z
    Biomed Pharmacother; 2018 Mar; 99():72-80. PubMed ID: 29324315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The emerging role of KDM5A in human cancer.
    Yang GJ; Zhu MH; Lu XJ; Liu YJ; Lu JF; Leung CH; Ma DL; Chen J
    J Hematol Oncol; 2021 Feb; 14(1):30. PubMed ID: 33596982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone H3 binding to the PHD1 domain of histone demethylase KDM5A enables active site remodeling.
    Longbotham JE; Chio CM; Dharmarajan V; Trnka MJ; Torres IO; Goswami D; Ruiz K; Burlingame AL; Griffin PR; Fujimori DG
    Nat Commun; 2019 Jan; 10(1):94. PubMed ID: 30626866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A.
    Horton JR; Woodcock CB; Chen Q; Liu X; Zhang X; Shanks J; Rai G; Mott BT; Jansen DJ; Kales SC; Henderson MJ; Cyr M; Pohida K; Hu X; Shah P; Xu X; Jadhav A; Maloney DJ; Hall MD; Simeonov A; Fu H; Vertino PM; Cheng X
    J Med Chem; 2018 Dec; 61(23):10588-10601. PubMed ID: 30392349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lysine-14 acetylation of histone H3 in chromatin confers resistance to the deacetylase and demethylase activities of an epigenetic silencing complex.
    Wu M; Hayward D; Kalin JH; Song Y; Schwabe JW; Cole PA
    Elife; 2018 Jun; 7():. PubMed ID: 29869982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure of the Arabidopsis JMJ14-H3K4me3 Complex Provides Insight into the Substrate Specificity of KDM5 Subfamily Histone Demethylases.
    Yang Z; Qiu Q; Chen W; Jia B; Chen X; Hu H; He K; Deng X; Li S; Tao WA; Cao X; Du J
    Plant Cell; 2018 Jan; 30(1):167-177. PubMed ID: 29233856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors.
    Liang J; Labadie S; Zhang B; Ortwine DF; Patel S; Vinogradova M; Kiefer JR; Mauer T; Gehling VS; Harmange JC; Cummings R; Lai T; Liao J; Zheng X; Liu Y; Gustafson A; Van der Porten E; Mao W; Liederer BM; Deshmukh G; An L; Ran Y; Classon M; Trojer P; Dragovich PS; Murray L
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2974-2981. PubMed ID: 28512031
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.